Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data

The integration of transcriptome and proteome analysis can lead to the discovery of a myriad of biological insights into ovarian cancer. Proteome, clinical, and transcriptome data about ovarian cancer were downloaded from TCGA’s database. A LASSO–Cox regression was used to uncover prognostic-related...

Full description

Bibliographic Details
Main Authors: Jinghang Jiang, Zhongyuan Chen, Honghong Wang, Yifu Wang, Jie Zheng, Yi Guo, Yonghua Jiang, Zengnan Mo
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/13/4/685
_version_ 1827745674506010624
author Jinghang Jiang
Zhongyuan Chen
Honghong Wang
Yifu Wang
Jie Zheng
Yi Guo
Yonghua Jiang
Zengnan Mo
author_facet Jinghang Jiang
Zhongyuan Chen
Honghong Wang
Yifu Wang
Jie Zheng
Yi Guo
Yonghua Jiang
Zengnan Mo
author_sort Jinghang Jiang
collection DOAJ
description The integration of transcriptome and proteome analysis can lead to the discovery of a myriad of biological insights into ovarian cancer. Proteome, clinical, and transcriptome data about ovarian cancer were downloaded from TCGA’s database. A LASSO–Cox regression was used to uncover prognostic-related proteins and develop a new protein prognostic signature for patients with ovarian cancer to predict their prognosis. Patients were brought together in subgroups using a consensus clustering analysis of prognostic-related proteins. To further investigate the role of proteins and protein-coding genes in ovarian cancer, additional analyses were performed using multiple online databases (HPA, Sangerbox, TIMER, cBioPortal, TISCH, and CancerSEA). The final resulting prognosis factors consisted of seven protective factors (P38MAPK, RAB11, FOXO3A, AR, BETACATENIN, Sox2, and IGFRb) and two risk factors (AKT_pS473 and ERCC5), which can be used to construct a prognosis-related protein model. A significant difference in overall survival (OS), disease-free interval (DFI), disease-specific survival (DSS), and progression-free interval (PFI) curves were found in the training, testing, and whole sets when analyzing the protein-based risk score (<i>p</i> < 0.05). We also illustrated a wide range of functions, immune checkpoints, and tumor-infiltrating immune cells in prognosis-related protein signatures. Additionally, the protein-coding genes were significantly correlated with each other. EMTAB8107 and GSE154600 single-cell data revealed that the genes were highly expressed. Furthermore, the genes were related to tumor functional states (angiogenesis, invasion, and quiescence). We reported and validated a survivability prediction model for ovarian cancer based on prognostic-related protein signatures. A strong correlation was found between the signatures, tumor-infiltrating immune cells, and immune checkpoints. The protein-coding genes were highly expressed in single-cell RNA and bulk RNA sequencing, correlating with both each other and tumor functional states.
first_indexed 2024-03-11T05:11:48Z
format Article
id doaj.art-2b00fd3d44f84ccfa16269ffa0bc8874
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-11T05:11:48Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-2b00fd3d44f84ccfa16269ffa0bc88742023-11-17T18:29:54ZengMDPI AGBiomolecules2218-273X2023-04-0113468510.3390/biom13040685Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic DataJinghang Jiang0Zhongyuan Chen1Honghong Wang2Yifu Wang3Jie Zheng4Yi Guo5Yonghua Jiang6Zengnan Mo7Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, ChinaCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, ChinaCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, ChinaCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, ChinaCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, ChinaCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, ChinaCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, ChinaCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, ChinaThe integration of transcriptome and proteome analysis can lead to the discovery of a myriad of biological insights into ovarian cancer. Proteome, clinical, and transcriptome data about ovarian cancer were downloaded from TCGA’s database. A LASSO–Cox regression was used to uncover prognostic-related proteins and develop a new protein prognostic signature for patients with ovarian cancer to predict their prognosis. Patients were brought together in subgroups using a consensus clustering analysis of prognostic-related proteins. To further investigate the role of proteins and protein-coding genes in ovarian cancer, additional analyses were performed using multiple online databases (HPA, Sangerbox, TIMER, cBioPortal, TISCH, and CancerSEA). The final resulting prognosis factors consisted of seven protective factors (P38MAPK, RAB11, FOXO3A, AR, BETACATENIN, Sox2, and IGFRb) and two risk factors (AKT_pS473 and ERCC5), which can be used to construct a prognosis-related protein model. A significant difference in overall survival (OS), disease-free interval (DFI), disease-specific survival (DSS), and progression-free interval (PFI) curves were found in the training, testing, and whole sets when analyzing the protein-based risk score (<i>p</i> < 0.05). We also illustrated a wide range of functions, immune checkpoints, and tumor-infiltrating immune cells in prognosis-related protein signatures. Additionally, the protein-coding genes were significantly correlated with each other. EMTAB8107 and GSE154600 single-cell data revealed that the genes were highly expressed. Furthermore, the genes were related to tumor functional states (angiogenesis, invasion, and quiescence). We reported and validated a survivability prediction model for ovarian cancer based on prognostic-related protein signatures. A strong correlation was found between the signatures, tumor-infiltrating immune cells, and immune checkpoints. The protein-coding genes were highly expressed in single-cell RNA and bulk RNA sequencing, correlating with both each other and tumor functional states.https://www.mdpi.com/2218-273X/13/4/685ovarian cancerproteometranscriptometumor-infiltrating immune cellssingle cell
spellingShingle Jinghang Jiang
Zhongyuan Chen
Honghong Wang
Yifu Wang
Jie Zheng
Yi Guo
Yonghua Jiang
Zengnan Mo
Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
Biomolecules
ovarian cancer
proteome
transcriptome
tumor-infiltrating immune cells
single cell
title Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_full Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_fullStr Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_full_unstemmed Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_short Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_sort screening and identification of a prognostic model of ovarian cancer by combination of transcriptomic and proteomic data
topic ovarian cancer
proteome
transcriptome
tumor-infiltrating immune cells
single cell
url https://www.mdpi.com/2218-273X/13/4/685
work_keys_str_mv AT jinghangjiang screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT zhongyuanchen screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT honghongwang screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT yifuwang screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT jiezheng screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT yiguo screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT yonghuajiang screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT zengnanmo screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata